| Popular Products & Programs |
|
|
| |
Phendimetrazine |
 |
Introduction & Overview |
Phendimetrazine is a prescription drug marketed as fighting severe cases of obesity. The pill is advertised as a short-term supplement, which is designed to suppress the appetite. This common method of weight management is said to promote a reduction in caloric intake. We find that there are many similar supplements available today.
While some people may need a prescription-strength drug to overcome certain conditions, we find that there are an increasing number of natural supplements on the market. Natural formulations may cause fewer side effects than those containing artificial stimulants. We will review this drug to determine what its strengths and weaknesses may be.
|
| Pros |
• Drug is advertised as effectively suppressing the appetite
• Those with health insurance may be eligible to get the drug for free
|
| Cons |
• Side effects may include dizziness, restlessness and blurred vision
• Users may become physically and psychologically dependent on drug
• Only available by prescription at time of review
• Advertised as a short-term method of managing weight
|
| Products Formula |
The drug is classified as a “sympathomimetic amine,” which is said to function in a similar way to amphetamines. We find it is also identified as an anorectic or anorexigenic pill. It is advertised as suppressing the appetite by stimulating the central nervous system, which may increase both heart rate and blood pressure. This may affect each user differently.
Trade names for the drug include: Anorex-SR, Appecon, Bontril Slow-Release, Melfiat, Obezine, Phendiet, Prelu-2 and Statobex. The drug seems to be similar to Phentermine, another prescription pill designed to suppress the appetite. These pills are intended for short term use, but lasting weight loss is believed to be dependent on long-term goals.
|
| Formula In Depth |
Phendimetrazine, like most prescription drugs, is known to have a number of associated side effects. Less serious, common side effects include restlessness, nervousness, anxiety, headaches and dizziness, insomnia, dry mouth and diarrhea. The following serious side effects may also occur: irregular heartbeat, hallucinations and blurred vision.
Because of the potential side effects, users are advised not to drive or operate machinery if at all possible. The drug is also said to be habit-forming; individuals may become dependent on the pill both physically and psychologically. For this reason, people with histories of drug addiction and abuse are warned against using it.
|
| Similar Pills |
While some side effects may be mild, the risk of more serious effects leads us to take a good look at all-natural, over-the-counter formulations. We find there is a host of weight loss supplements on the market advertised to produce effects similar to this drug, only without the negative side effects. Some are proven to contain highly potent ingredients.
Examples of herbal ingredients advertised to suppress the appetite include Guarana Seed Extract, Caralluma Fimbriata and Hoodia Gordonii. Supplements may include some or all of these ingredients. We feel that Hoodia seems to show the most promise as an appetite suppressant; most manufacturers appear to have a Hoodia-based pill in their line-up.
|
| Conclusion |
Phendimetrazine seems to be recommended for individuals as a last resort — only if they have tried everything else and nothing has worked for them. However, we believe that lack of will power may be the culprit in many failed weight loss plans, more than anything else. With proper nutrition, regular exercise and good supplementation, individuals may be able to reach their weight loss goals.
We conclude that while the drug may be somewhat useful as an appetite suppressant, the risk of harmful side effects leads us to consider using alternative weight loss methods. We find that Hoodia, as mentioned above, is one of the promising appetite suppressants on the market. Some companies offer free trials, and some boast a knowledgeable customer support team.
|
|
|
|
| |
|
|
|
